◼ Archived
Business
🔮 holds ✗
FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly
The FDA has granted clearance to a new Alzheimer’s disease blood test developed by Roche and Eli Lilly.
Roche
3 independently sourced, verified trend briefs about this subject.
What this topic page includes
Newsylist includes a story here only after at least four independent sources support it and its brief passes the verification check. The qualifying coverage spans 2 news categories, from Jul 2, 2026 through Aug 26, 2026.
The cards below are ordered newest first. Each opens the underlying timeline, source list, coverage velocity and verification context; raw or extractive-only records are excluded.
◼ Archived
Health
🔮 holds ✓
New Alzheimer’s drug could stop disease
Emerging Alzheimer’s drug candidates are generating global attention as researchers and health advocates evaluate their potential to stop the disease.
◼ Archived
Business
🔮 holds ✗
Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial
Roche's drug candidate divarasib outperformed rival therapies in a Phase 3 trial for KRAS-driven lung cancer.